?

Johnson Craig A

Director
Heron Therapeutics, Inc.
US, San Diego [HQ]
CIK 1370348

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
65,820
Price per Share :
$1.52
Equivalence :
$100,046.40

Transaction History

  • A
    Form 4
    65,820 Shares After Transaction
    Value : $n/a
    $0.0
    01/19/24
  • Footnotes:
    #1 The shares were granted as restricted stock units which vest in full on January 19, 2025.